The Vitals | Rises and Advancements in Colorectal Cancer

Why It Matters

Early‑onset colorectal cancer threatens a growing demographic, demanding revised screening protocols and heightened public awareness to improve outcomes and reduce mortality.

Key Takeaways

• Colorectal cancer now leading cancer death under age 50 in US
• Early antibiotic exposure, diet, and sedentary lifestyle suspected drivers
• Symptoms like rectal bleeding, weight loss, and stool changes require prompt evaluation
• Colonoscopy remains gold standard; FIT, Cologuard, and capsule endoscopy are alternatives
• Emerging blood‑based DNA tests may reduce colonoscopies but lack polyp detection

Summary

The Vitals episode spotlights a troubling shift – colorectal cancer, once seen as an older‑adult disease, is now the leading cause of cancer death in Americans under 50. Host Leslie Schlachter and three Mount Sinai specialists discuss why younger patients are being diagnosed and what it means for screening.

The doctors cite a recent study placing colorectal cancer at the top of cancer‑related mortality for those under 50, echoing trends they see in endoscopy clinics. While the exact cause remains unclear, they point to obesity, red‑meat diets, alcohol, smoking, early antibiotic exposure, and microbiome disruption as leading hypotheses.

Dr. Cohen emphasizes that symptoms such as rectal bleeding, persistent abdominal pain, unexplained weight loss, or changes in stool caliber should prompt immediate evaluation, not dismissal as hemorrhoids. The panel reviews screening tools – FIT, Cologuard, colonoscopy, CT colonography, capsule endoscopy – and notes that GLP‑1 agonists can mask warning signs by causing constipation.

The discussion underscores a shift toward broader, earlier screening and the promise of blood‑based DNA tests that could spare many invasive colonoscopies, though current assays miss precancerous polyps. For clinicians and policymakers, the episode signals urgency in updating guidelines and public education to curb the rising tide of early‑onset colorectal cancer.

Original Description

Colorectal cancer is no longer just a disease of older adults—and the data is raising alarm bells.

On this episode of The Vitals, host Leslie Schlachter sits down with the Mount Sinai Health System’s leading experts

To unpack why rates are rising, especially among younger populations, and what you need to know right now.

Joining the conversation are gastroenterologists Dr. David Greenwald and Dr. Pascale White, along with medical oncologist Dr. Deirdre Cohen. Together, they explore the latest research, evolving screening guidelines, and breakthrough treatments that are changing outcomes for patients.

From early warning signts to cutting-edge therapies, this episode delivers practical, evidence-based insights that could change lives:

The likely reasons why colorectal cancer is increasing in adults under 50;

Common symptoms you should never ignore;

Screening options—from stool tests to colonoscopy—and when to start;

The role of lifestyle, diet, and the microbiome;

Advances in treatment, including immunotherapy and personalized medicine;

How early detection dramatically improves survival.

Colorectal cancer is one of the most preventable—and treatable—cancers when caught early. Whether you’re approaching screening age or simply want to stay informed, this conversation is essential listening.

🎤 Subscribe to The Vitals for more conversations on the people and innovations advancing medicine today: https://www.youtube.com/playlist?list=PLCT7BA-HcHliU8QIXyuk_74L_uH0gyKGt

📞For more information on Mount Sinai’s colorectal cancer treatments or to schedule an appointment with a Mount Sinai physician, click here: https://www.mountsinai.org/care/gastroenterology/services/endoscopy-colonoscopy/colonoscopy/colorectal-screening

#TheVitals #ColorectalCancer #CancerPrevention #Healthcare #MountSinai

00:00 – Introduction & episode overview

00:45 – Meet the experts

01:05 – Rising colorectal cancer rates in younger adults

03:15 – Alcohol, smoking, and lifestyle risks

04:10 – The microbiome & antibiotic exposure

06:35 – Symptoms you should never ignore

07:40 – GLP-1 medications & symptom confusion

08:40 – Blood in stool: what it really means

09:30 – Screening options explained (FIT, Cologuard, colonoscopy)

11:15 – At-home tests vs. colonoscopy

12:45 – Blood tests & future screening innovations

15:10 – When should you get screened? (Age 45 guideline)

17:40 – What happens during a colonoscopy

19:00 – Treatment options: surgery, chemo, radiation

20:30 – Immunotherapy & precision medicine

23:20 – How long does treatment last?

23:50 – Clinical trials & emerging therapies

25:40 – Multidisciplinary care & tumor boards

30:00 – Artificial intelligence in colonoscopy

31:40 – Biggest myths about colorectal cancer

33:30 – Disparities in diagnosis & outcomes

34:00 – Why colorectal cancer is not a death sentence

38:00 – Real patient stories & life-saving screenings

41:20 – Colonoscopy prep: what to expect now

44:30 – Prevention: diet, exercise, and lifestyle

46:00 – Final takeaways